TrialPharmaceutical research2013

Diclofenac enables unprecedented week-long microneedle-enhanced delivery of a skin impermeable medication in humans.

Nicole K Brogden et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.